| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | $1.0B | $1.0B | $1.0B | $1.2B | $1.2B | $0.8B | $0.9B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | $0.8B | $0.8B |
| Operating Income | $0.1B | $-0.0B | $0.5B | $0.1B | $0.1B | $0.1B | $0.2B | $-0.4B |
| Net Income | $-0.6B | $-0.7B | $-0.1B | $-0.2B | $-0.4B | $-0.0B | $0.0B | $-0.2B |
| EPS (Basic) | $-3.06 | $-3.31 | $-0.35 | $-0.79 | $-1.89 | — | — | — |
| EPS (Diluted) | $-3.06 | $-3.31 | $-0.35 | $-0.79 | $-1.89 | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.2B | $12.8B | $13.6B | $13.6B | $15.4B | $15.2B | $14.9B | $13.4B |
| Current Assets | $2.2B | $2.1B | $2.4B | $2.1B | $2.1B | $2.0B | $2.1B | $1.6B |
| Cash & Equivalents | $0.8B | $0.7B | $1.0B | $0.8B | $1.0B | $0.9B | $1.2B | $0.6B |
| Total Liabilities | $11.2B | $11.2B | $11.3B | $11.0B | $12.5B | $11.8B | $11.0B | $9.3B |
| Current Liabilities | $2.0B | $2.0B | $2.1B | $1.8B | $1.5B | $1.7B | $1.6B | $1.6B |
| Stockholders' Equity | $0.6B | $1.1B | $1.8B | $1.9B | $2.2B | $2.7B | $3.1B | $3.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.8B | $0.8B | $0.9B | $0.9B | $1.0B | $0.6B | $0.9B | $0.8B |
| Investing Cash Flow | $-0.6B | $-0.7B | $-0.6B | $-1.1B | $-1.3B | $-2.5B | $-0.6B | $-1.0B |
| Capital Expenditures | — | — | — | $0.8B | $0.9B | $0.6B | $0.7B | $0.8B |
| Financing Cash Flow | $-0.0B | $-0.4B | $-0.1B | $-0.0B | $0.4B | $0.3B | $1.5B | $0.3B |